Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon gamma (IFN-γ) production is the process by which immune cells—primarily activated T lymphocytes (such as Th1 CD4+ cells and CD8+ cytotoxic T cells), natural killer (NK) cells, some γδ T cells, and, to a lesser extent, antigen-presenting cells—produce and secrete the cytokine interferon gamma in response to immune stimuli[1][2][5][7]. IFN-γ is a type II interferon and a major regulator of innate and adaptive immunity, playing central roles in antiviral and antitumor defense, activation of macrophage microbicidal activity, immunomodulation (e.g., upregulation of MHC class I and II), and orchestration of inflammatory responses[1][6][7]. The production of IFN-γ is tightly regulated and is induced by cytokines such as IL-12 and IL-18, as well as antigenic stimulation[4][5]. Dysregulation of IFN-γ production is associated with pathological conditions including autoimmunity, chronic inflammation, and certain infections and cancers[1][7].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon gamma production (null).